<div class="lt">

            <div class="lt-header clear">

                <div class="header-title clear">

                    <a title="抗Scl-70抗体测定">

                        <span class="title-lt">抗Scl-70抗体测定</span>

                    </a>

                    

                </div>

                <div class="header-message clear">

                    <div class="message-boxs">

                        1979年Douvas等首先应用免疫双扩散法发现硬皮病患者血清中存在一种与小牛胸腺核提取物成分反应的自身抗体，因该自身抗体对硬皮病高度特异且反应蛋白分子量为70kD，故称为抗Scl-70抗体或抗硬皮病70抗体。1986年Shero等首先确定了抗Scl-70抗体的靶抗原是DNA拓扑异构酶1（Topoisomerase 1 ，简称Top1），故抗Scl-70抗体又称为抗拓扑异构酶1抗体（抗Top1抗体）。抗Scl-70抗体的靶抗原位于DNA拓扑异构酶1的C端末区，存在于核浆与核仁中，在核仁中的浓度尤其高。该酶天然蛋白分子量为100kD，最初在免疫印迹实验中仅发现客观存在的分子量为70kD的降解物。经研究证实低于100kD分子量的蛋白是在纯化过程中被蛋白酶降解的产物。该酶在DNA双链的复制和转录中起作用，参与超螺旋DNA的解螺旋，使DNA能形成复制与转录的所需的拓扑结构，是细胞内具有重要生物功能的关键蛋白。抗Scl-70抗体为系统性硬皮病的血清标记性抗体，对系统性硬皮病的诊断及鉴别诊断有重要临床价值。

                    </div>

                </div>

                <div class="header-list clear">

                    <div class="list">

                        <div class="list-label clear">

                            <span class="list-label">【标准名称】：</span>

                            <div class="list-text">

                                <span>抗Scl-70抗体测定</span><br />

                            </div>

                        </div>

                        <div class="list-label clear">

                            <span class="list-label">【英文名称】：</span>

                            <div class="list-text">

                                <span>无</span><br />



                            </div>

                        </div>

                        <div class="list-label clear">

                            <span class="list-label">【分类】：</span>

                            <div class="list-text">

                                <span>自身免疫病的实验项目</span>

                            </div>

                        </div>

                    </div>

                    <div class="list">



                        <div class="list-label clear">

                            <span class="list-label">【别名】：</span>

                            <div class="list-text">

                                <span>无</span>

                            </div>

                        </div>

                        <div class="list-label clear">

                            <span class="list-label">【缩写名】：</span>

                            <div class="list-text">

                                <span></span><br />

                            </div>

                        </div>

                    </div>

                </div>

            </div>

            <div class="lt-main">

<div class="nav-wrapper">

    <div class="aBox">

        

                



    </div>

</div>

<div class="disease-viewbox" id="JBgs">

    <div class="labels-wrapper">

        <div class="labels-top">

            <ul>

                    <li><a class="#label_Indication">检查适应证</a></li>

                    <li><a class="#label_Reference">参考值</a></li>

                    <li><a class="#label_Clinical">临床意义</a></li>

                    <li><a class="#label_Samples">标本要求</a></li>

                    <li><a class="#label_Precautions">检查注意事项</a></li>

            </ul>

        </div>

    </div>

    <div class="float-labels">

        <div class="labels-top">

            <ul>

                    <li><a class="#label_Indication">检查适应证</a></li>

                    <li><a class="#label_Reference">参考值</a></li>

                    <li><a class="#label_Clinical">临床意义</a></li>

                    <li><a class="#label_Samples">标本要求</a></li>

                    <li><a class="#label_Precautions">检查注意事项</a></li>

            </ul>

        </div>

    </div>

            <div class="pathogenesis">

                    <div class="p-title  clear">

        <div class="line"></div>

        <span class="text"><a id="label_Indication">检查适应证</a></span>

    </div>



        <div class="p-main clear">

            <div class="p">

                <div>

                    怀疑<a>硬皮病</a>患者。

                </div>

            </div>

        </div>

            </div>

            <div class="pathogenesis">

                    <div class="p-title  clear">

        <div class="line"></div>

        <span class="text"><a id="label_Reference">参考值</a></span>

    </div>



        <div class="p-main clear">

            <div class="p">

                <div>

                    阴<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />。

                </div>

            </div>

        </div>

            </div>

            <div class="pathogenesis">

                    <div class="p-title  clear">

        <div class="line"></div>

        <span class="text"><a id="label_Clinical">临床意义</a></span>

    </div>



        <div class="p-main clear">

            <div class="p">

                <div>

                    <a>抗Scl-70抗体</a>被视为进行<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' /><a>硬皮病</a>（PSS）的血清特异<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />抗体。未经选择的系统<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />硬化症（SSc）病人中，<a>抗Scl-70抗体</a>阳<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />率为25%（ID法）～ 40%（IB法），重症弥漫型为75%，CREST综合症为13%，PM/Scl重叠综合症为12%。局限型<a>硬皮病</a>患者此抗体一般为阴<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />。<a>抗Scl-70抗体</a>对诊断SSc的特异<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />为100%，敏感<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />为40%。该抗体阳<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />与弥漫<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />皮肤病变、近端皮肤累及、肺间质纤维化、心脏受累、肾脏受累、远侧骨质溶解、指端凹陷<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />疤痕、指趾关节畸形、并发肿瘤及神经系统受累密切相关，被视为预后不良的指标。在其与HIA相关<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />的研究中发现，<a>抗Scl-70抗体</a>阳<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />与HIA-DR5、-B8、-DR3、-DR52、-DRw11、-DR2的关系密切。由于<a>抗Scl-70抗体</a>在其他结缔组织病和非结缔组织病极少阳<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />，因此该抗体可称为系统<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' /><a>硬皮病</a>的血清标记<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/30F48CD3C7E73511070B95EE0A884C23.jpg'  align='absmiddle' />抗体。

                </div>

            </div>

        </div>

            </div>

            <div class="pathogenesis">

                    <div class="p-title  clear">

        <div class="line"></div>

        <span class="text"><a id="label_Samples">标本要求</a></span>

    </div>



        <div class="p-main clear">

            <div class="p">

                <div>

                    人血清或EDTA、肝素、<a>柠檬酸</a>盐抗凝的血浆。常规普通管静脉血标本2ml，常规分离血清，2～8℃保存。待测<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/176BF6219855A6EB1F3A30903E34B6FB.jpg'  align='absmiddle' />本在2～8℃可以保存14天。已稀释的<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/176BF6219855A6EB1F3A30903E34B6FB.jpg'  align='absmiddle' />本必须当天检测。

                </div>

            </div>

        </div>

            </div>

            <div class="pathogenesis">

                    <div class="p-title  clear">

        <div class="line"></div>

        <span class="text"><a id="label_Precautions">检查注意事项</a></span>

    </div>



        <div class="p-main clear">

            <div class="p">

                <div>

                    如严重脂血或严重溶血标<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/64DAD26CF76950A7F6AF16DFE56DF596.jpg'  align='absmiddle' />，应重<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/70F296A228590278B6CA704EFCCFD18A.jpg'  align='absmiddle' />留取合格标<img src='http://www.wanfangmed.com.cn/ImageServer/newlczl/Content/textImage/64DAD26CF76950A7F6AF16DFE56DF596.jpg'  align='absmiddle' />送检。

                </div>

            </div>

        </div>

            </div>



    <div id="DivBigAppend"></div>

        

</div>

    <div class="lcwx-box" id="loadPaper"></div>

            </div>

            </div>